Revolutionizing Healthcare: The Impact of AI Disruption in Clinical Trials

Fierce JPM Week 2023

Every January, healthcare companies from around the world descend in California at the annual JPM Healthcare Conference. This year, the topic of artificial intelligence (AI) dominated the sessions.

H1 CEO Ariel Katz led a panel focused on the integration of AI in clinical trials and the profound transformation and impact on the efficiency, accuracy, and innovation in trial design as a result. Panelists examined how the application of AI in patient recruitment, data analysis, and personalized medicine can provide unprecedented opportunities that will reshape the future of healthcare.

Industry leaders on the panel included:

Watch the panel in action; view the discussion now.